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STEM CELLS AND REGENERATION RESEARCH ARTICLE
Gli3 controls the onset of cortical neurogenesis by regulating
the radial glial cell cycle through Cdk6 expression
Kerstin Hasenpusch-Theil1, Stephen West1, Alexandra Kelman1, Zrinko Kozic1, Sophie Horrocks1,
Andrew P. McMahon2, David J. Price1, John O. Mason1 and Thomas Theil1,*
ABSTRACT
The cerebral cortex contains an enormous number of neurons,
allowing it to perform highly complex neural tasks. Understanding
how these neurons develop at the correct time and place and in
accurate numbers constitutes amajor challenge.Here,we demonstrate
a novel role for Gli3, a key regulator of cortical development, in cortical
neurogenesis. We show that the onset of neuron formation is delayed
in Gli3 conditional mouse mutants. Gene expression profiling and cell
cycle measurements indicate that shortening of the G1 and S phases
in radial glial cells precedes this delay. Reduced G1 length correlates
with an upregulation of the cyclin-dependent kinase gene Cdk6, which
is directly regulated by Gli3. Moreover, pharmacological interference
with Cdk6 function rescues the delayed neurogenesis in Gli3 mutant
embryos. Overall, our data indicate that Gli3 controls the onset of
cortical neurogenesis by determining the levels of Cdk6 expression,
thereby regulating neuronal output and cortical size.
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INTRODUCTION
The ordered formation of neurons in sufficient numbers and at the
correct time and place underlies the functioning of the cerebral cortex
and its ability to perform highly complex neural tasks and to confer
humans with their unique cognitive capabilities. Central to generating
appropriate numbers of neurons are cortical stem and progenitor
cells and the control of their proliferation and differentiation rates.
Changes in these parameters can have profound effects on cortical
size and have been proposed to underlie cortical malformations in
human disease as well as the expansion of the human cerebral
cortex during evolution (Florio and Huttner, 2014). During murine
corticogenesis, there are two major types of stem and progenitor
cells: radial glial cells (RGCs) and basal progenitors (BPs), which
can be characterized by the expression of the transcription factors
Pax6 and Tbr2 (also known as Eomes), respectively (Englund
et al., 2005; Götz et al., 1998; Warren et al., 1999). RGCs extend
apical and basal processes and present with an apico-basal polarity
(Götz and Huttner, 2005). They divide at the apical surface of the
ventricular zone to undergo either symmetric proliferative divisions to
expand the progenitor pool or asymmetric self-renewing divisions
to produce an RGC daughter cell and either a neuron or a BP (Götz
and Huttner, 2005). BPs are born from RGCs, have no apical contact
and settle in a more basal position to form the subventricular zone.
Most BPs divide directly into two neurons, whereas the remainder
undergo one round of symmetric proliferative division before
differentiating into two neurons (Haubensak et al., 2004; Miyata
et al., 2004; Noctor et al., 2004).
The switch from symmetric proliferative divisions to asymmetric
divisions in RGCs is crucial to determine neuron numbers and
cortical size and is controlled by cell-extrinsic as well as cell-intrinsic
mechanisms. Fgf10 and retinoic acid are produced by neuroepithelial
cells and by the meninges, respectively, and control the transition
between these division modes, thereby regulating cortical neuron
formation (Haushalter et al., 2017; Sahara and O’Leary, 2009;
Siegenthaler et al., 2009), whereas Notch/Delta signalling between
neural progenitors is essential for progenitor self-renewal by
regulating the activity of the Hes transcription factors (Kageyama
et al., 2008; Pierfelice et al., 2011). Moreover, there is increasing
evidence for a pivotal role of the cell cycle as a cell-intrinsic control
mechanism to determine the balance between RGC proliferation
and differentiation. In particular, the length of the G1 phase
correlates with the neurogenic fate of cortical cell divisions.
Early during corticogenesis, cortical progenitors have a shorter
G1 and undergo proliferative divisions whereas G1 becomes
longer for neurogenic divisions at later stages (Miyama et al.,
1997). Moreover, G1 lengthening alone is sufficient to induce
neurogenesis and shortening G1 inhibits neuron formation (Lange
et al., 2009; Pilaz et al., 2009). Although these studies clearly
demonstrate the importance of the cell cycle in regulating the
switch from proliferative to neurogenic divisions in RGCs, it
remains largely unexplored how cell cycle length itself is controlled
at the onset of cortical neurogenesis.
The evolutionarily highly conserved zinc-finger transcription
factor Gli3 is well positioned to combine roles in early cortical
development with the timing of neuron formation.Gli3 is essential
for patterning the telencephalon (Theil et al., 1999; Tole et al.,
2000) by repressing Shh signalling and by also acting in a Shh-
independent manner (Rash and Grove, 2007). Recent single-cell
mRNA-seq experiments identified GLI3 as an RGC-specific
marker in human cortex (Pollen et al., 2015, 2014). Gli3 has been
implicated in murine cortical stem cell development after
mid-corticogenesis when it regulates cortical growth (Palma
and Ruiz i Altaba, 2004; Wang et al., 2011). Gli3 also helps to
establish the adult neurogenic niche by repressing Il6st and Numb
gene expression (Wang et al., 2014). Strikingly, the earliest born
cortical neurons are severely reduced and/or completely lost
in the Gli3 mutant forebrain (Magnani et al., 2010, 2013; Theil,
2005), strongly suggesting a role in controlling the transition fromReceived 9 January 2018; Accepted 13 July 2018
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symmetric to asymmetric division in RGCs, but the underlying
mechanisms remain unexplored. Here, we demonstrate that
conditional inactivation of Gli3 in cortical RGCs leads to a
delay in cortical neuron formation that coincides with an increase
in cortex size and a reduced proportion of deep layer neurons.
Gene expression profiling indicates that altered expression of cell
cycle genes precedes this neurogenesis defect. Indeed, the cell
cycle length of Gli3 mutant RGCs is shortened as a result of
reduced lengths of the G1 and S phases. Mechanistically, Gli3
binds to the promoter of the Cdk6 gene, a key regulator of
G1 phase length (Choi and Anders, 2014), in vitro and in vivo
and represses Cdk6 transcription. Interfering with Cdk6
activity rescues the delayed neurogenesis in Gli3 conditional
mutants. Taken together, these findings establish Gli3 as a novel
regulator of the RGC cell cycle and show that Gli3 regulates cell
cycle length and thereby cortical neurogenesis by controlling
Cdk6 expression.
RESULTS
Cortical neurogenesis is delayed in Gli3mutant embryos
To address which cortical progenitor cell types express Gli3 protein,
we performed Gli3 double immunofluorescence staining with Pax6
and Tbr2 as markers for RGCs and BPs, respectively, on sections of
embryonic day (E) 12.5 cortex. This analysis revealed that Gli3 is
expressed in Pax6+ progenitors. Some Tbr2+ cells, mainly located
deep within the ventricular zone, also express Gli3 whereas BPs at
the upper side of the ventricular zone express little or no Gli3 protein
(Fig. S1). These findings indicate that Gli3 is predominantly
expressed in RGCs and becomes downregulated in BPs, as has been
described for Pax6 (Englund et al., 2005).
Given its expression in RGCs, Gli3 could regulate their
proliferation or their differentiation into BPs and cortical projection
neurons. To investigate such roles, we made use of Emx1Cre;Gli3fl/fl
(Gli3cKO) conditional mutants. In these embryos, Gli3 is inactivated
in the cortex in a gradient from medial to lateral with inactivation
being completed medially by E11.5 with the onset of neurogenesis.
In contrast, Gli3 protein expression in the lateral neocortex is only
lost by E12.5 when neurogenesis is already underway (Fig. S1).
Moreover, E12.5 Gli3cKO embryos can easily be distinguished from
control embryos by a prominent bulging of the rostral telencephalon
suggesting a severe growth defect (Fig. S2). Coronal sections through
the telencephalon revealed an elongation of the rostral midline
and a thinner cortex with lower numbers of cells per unit of
surface but no obvious defect in cortical patterning as described
previously (Amaniti et al., 2013) (Fig. 1A,B; Fig. S3). Given this
growth defect, we focussed our analysis of RGC development on
the rostromedial telencephalon of Gli3cKO embryos. We first
determined the proportions of RGCs, BPs and cortical neurons in
this region in E11.5 and E12.5 Gli3cKO embryos, i.e. at the
beginning of cortical neurogenesis. Double immunofluorescence
staining for PCNA, a marker of proliferating cells (Hall et al.,
1990), and the radial glial marker Pax6 revealed an increase in the
proportion of RGCs in E11.5 and E12.5 Gli3cKO embryos
(Fig. 1C-G). This rise coincided with a decreased proportion
of proliferating BPs and neurons at E11.5 as evidenced by
Tbr2/PCNA and Tbr1/TO-PRO-3 double staining, respectively
(Fig. 1H,I,L-N,Q). In contrast, the BP pool was increased by
E12.5, although the proportion of neurons remained decreased
(Fig. 1J-L,O-Q). Taken together, these findings indicate that the
formation of BPs and cortical neurons is delayed inGli3cKO embryos,
suggesting that Gli3 controls the timing of RGC differentiation into
BPs and neurons.
Reduced cell cycle exit and decreased formation of deep
layer neurons in Gli3cKO mutants
To determine whether reduced neuron numbers inGli3mutants were
due to increased neural progenitor proliferation, we performed double
immunofluorescence experiments for PCNA and phosphohistone H3
(pHH3), which labels mitotic RGCs at the ventricular surface and
dividing BPs in abventricular positions. This analysis confirmed
increased proportions of RGCs and BPs undergoing mitosis in E11.5
Gli3cKO embryos (Fig. 2A,B,E,F). This effect is also maintained in
E12.5 mutant BPs but not in RGCs (Fig. 2C-F). We also investigated
the possibility of altered cell cycle exit using bromodeoxyuridine
(BrdU) pulse-chase experiments. BrdU was given to pregnant mice
24 h before dissecting the embryos and PCNA staining was used to
reveal all proliferating cells. This analysis showed that the fraction
of cells leaving the cell cycle and differentiating into neurons
(BrdU+/PCNA−) was significantly reduced in E12.5 Gli3cKO
embryos, consistent with the reduced proportions of neurons in
these areas (Fig. 2G,H,K). This analysis suggests that alterations in
proliferation and cell cycle exit underlie the changes in neuronal
proportions in Gli3 mutants.
Next, we investigated the consequences of this delayed cortical
neurogenesis on cortical size and layer formation. We predicted
that a delay in early neuron generation would result in an enlarged
cortex and in reduced proportions of deep layer neurons. We first
confirmed a reduction in the formation of early-born neurons in the
Gli3cKO cortex using a BrdU pulse-labelling experiment in which
BrdU was injected into pregnant dams at the E12.5 stage and
embryos were recovered at E17.5 (Fig. 2I-K). Next, we measured
cortical surface area, which was significantly increased in Gli3cKO
brains (Fig. 3A-C). Measurements on coronal sections also revealed
an enlarged ventricular surface and a thicker cortex in Gli3cKO
mutants (Fig. S4). We also used immunofluorescence labelling for
Tbr1 and Ctip2 (also known as Bcl11b) to investigate the formation
of layer VI and layer V neurons, respectively, whereas Satb2 served
as a layer II-IV neuronal marker. To this end, the neocortex was
subdivided into ten bins (bin ten being the deepest) and the
proportions, distribution and number of each neuronal subtype were
determined. This analysis revealed a reduced number and proportion
of early-born Tbr1+ neurons (Fig. S5) which settled in a narrower
band (Fig. 3D-F). This reduced size of the Tbr1+ layer coincided
with a shift of Ctip2+ neurons to a deeper location (Fig. 3G-I).
The proportion of Tbr1+Ctip2+ neurons mainly located in layer VI
was also decreased (Fig. 3M-O) and birthdating analyses showed a
delayed generation of Tbr1+ neurons inGli3cKO mutants (Fig. 3P-U).
In contrast, we observed an increase in the proportion and numbers
of Satb2+ neurons (Fig. 3J-L) (Fig. S5). Taken together, these
experiments led us to conclude that a reduced cell cycle exit at
early neurogenesis led to an increased cortical size and to the
reduced and delayed formation of Tbr1+ deep layer neurons in
Gli3cKO mutants.
Gli3 regulates the RGC cell cycle
To investigate the molecular mechanisms by which Gli3 regulates
RGC differentiation, we compared gene expression profiles in control
and Gli3cKO embryos by mRNA sequencing (mRNA-seq). To this
end, we dissected the rostromedial telencephalon from embryos at
E11.5 when the delay in BP and neuron formation started and at
E12.5 when BPs and neurons were formed. We found that 2515 and
458 genes were differentially regulated inGli3cKO embryos compared
with control embryos at E11.5 and E12.5, respectively (P<0.05)
(Table S3). Gene ontology (GO) analysis using Genomatix Software
showed that differentially regulated genes are mostly involved in cell
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cycle regulation at E11.5 (GO terms: ‘mitotic cell cycle’, ‘cell cycle
phases’ and ‘G1/S transition’) and in neuronal differentiation at E12.5
(GO terms: ‘generation of neurons’ and ‘neuronal differentiation’)
(Fig. S6). Other regulated genes were involved in ‘DNA
replication’ and ‘nervous system development’ at E11.5 and in
‘cell differentiation’ and ‘forebrain development’ at E12.5,
consistent with known roles of Gli3 in cortical development.
The above findings indicate that alterations in the cell cycle of
RGCs precede and may underlie defects in neurogenesis in Gli3cKO
cortical progenitors. To test this idea, we first determined total
cell cycle length and that of individual cell cycle phases in control
and Gli3cKO embryos. We used iododeoxyuridine (IdU) and BrdU
double labelling to calculate total cell cycle and S-phase times
(Fig. 4A) (Martynoga et al., 2005; Nowakowski et al., 1989).
Fig. 1. Altered proportions of RGCs, BPs and neurons
in Gli3 conditional mutants. (A,B) Coronal sections of
E12.5 forebrains stained with DAPI and Pax6 illustrating
the overall morphology and the extent of the dorsal
telencephalon in Gli3cKO mutants. Boxes indicate the
region at which cell counts were performed. (C-G) Pax6/
PCNA double immunofluorescence staining determines
the proportion of RGCs. (G) The fraction of RGCs is
increased in E11.5 and E12.5 Gli3cKO embryos.
(H-L) Tbr2 and PCNA immunostaining on brain sections
showed that the proportion of BPs is decreased at E11.5
but increased at E12.5. (M-Q) Reduced proportions of
neurons in the rostromedial telencephalon of Gli3cKO
embryos as revealed by staining for Tbr1 and TO-PRO-3.
All statistical data are presented as mean±95%
confidence intervals (CI); n=4 (C-F,H-K,M,O) and n=6 (N,
P); *P<0.05; Mann–Whitney test. ctx, cortex; LGE, lateral
ganglionic eminence; MGE, medial ganglionic eminence.
Scale bars: in A, 250 µm for A,B; in D, 25 µm for C-F; in H,
50 µm for H-K,M-P.
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In addition, we combined BrdU labelling with immunostaining
for pHH3, an indicator of late G2 and M phase, to determine G2
length (Fig. 4B). To this end, embryos were harvested at different
time points after BrdU administration to identify when BrdU label
appears in mitotic figures. M-phase length was investigated by
analysing the proportion of progenitors that are in M phase by
pHH3 immunofluorescence compared with the total number of
progenitors as revealed by PCNA staining (Fig. 4C). Finally,
determining total cell cycle length and length of S, G2 and M
phase allowed us to calculate the length of the G1 phase. These
analyses revealed a shortening of the overall cell cycle in E11.5
Gli3cKO cortical progenitors coinciding with significantly shorter
G1 and S phases (Fig. 4D, Table 1 and Table S4). In contrast, the
cell cycle was elongated due to a lengthening of S phase in E12.5
Gli3cKO embryos (Fig. 4D, Table 1 and Table S4). Taken together,
these analyses revealed altered cell cycle times in Gli3cKO mutants
indicating that Gli3 has an important role in controlling the length
of the G1 and S phases.
Proportion of proliferating versus differentiating progenitors
and changes in S-phase length in Gli3mutants
Next, we investigated the causes for the changes in S-phase length
in Gli3 mutants. As transcription during S phase is limited, we
addressed whether Gli3 controls duration of S phase by an indirect
mechanism. Recently, it was shown that differentiating RGCs and
BPs have a shorter S phase than proliferative progenitors (Arai et al.,
2011) raising the possibility that the shortening of S phase in Gli3
mutants is caused by a higher proportion of progenitors that are
differentiating. These cells are characterized by Btg2 (Tis21)
expression (Iacopetti et al., 1999). Therefore, we generated Gli3
mutants carrying a Tis21-GFP transgene (Haubensak et al., 2004).
Double immunofluorescence for GFP and Pax6 revealed no
statistically significant change in the proportion of differentiating
RGCs in E11.5 Gli3cKO embryos but a decrease in E12.5 RGCs
(Fig. S7). In contrast, the proportion of differentiating BPs was
slightly increased at E11.5 (Fig. S7). However, as BPs only form a
small proportion of the overall cortical progenitor population in
the dorsomedial telencephalon, it is unlikely that this change
contributes to the changes in S-phase length in Gli3cKO mutants.
Gli3 directly represses Cdk6 expression
As a next step, we analysed the mechanisms by which Gli3 regulates
G1 duration. Among the cell cycle-regulated genes, cyclin-dependent
kinase 6 (Cdk6) was the most highly upregulated gene in Gli3cKO
embryos compared with controls (1.9-fold) (Table S3). Cdk6 has a
key role in controlling the transition between the G1 and S phases
of the cell cycle and thereby determines the length of the G1 phase
(Choi and Anders, 2014). The shorter G1 phase and its
upregulation in Gli3 mutant cortical progenitors made Cdk6 an
interesting candidate acting downstream of Gli3 to control the
length of the G1 phase.
We first validated the Cdk6 upregulation by quantitative
RT-PCR, which confirmed a 1.95- and 1.51-fold upregulation of
Cdk6 transcription in the rostromedial telencephalon of E11.5 and
E12.5 Gli3cKO embryos, respectively, (Fig. 5A) consistent with our
mRNA-seq data. Western blotting revealed a 1.35-fold upregulation
of the Cdk6 protein in the dorsal telencephalon of E12.5 Gli3cKO
embryos (Fig. 5B).
Next, we investigated the mechanism by which Gli3 regulates
Cdk6 expression. The upregulation of Cdk6 in Gli3cKO mutants
raises the possibility that Gli3 binds to the Cdk6 promoter and
directly represses its transcription. Chromatin immunoprecipitation
followed by deep sequencing identified several sites of Gli3
occupancy in the Cdk6 promoter region (Fig. 5C). Inspecting the
promoter sequence revealed two potential, evolutionarily conserved
Gli3-binding sites. Using electromobility shift assays (EMSAs), we
Fig. 2. Increased proliferation and reduced cell
cycle exit in Gli3cKO mutants. (A-D) Sections of
E11.5 and E12.5 control and Gli3cKO embryos
stained with pHH3/PCNA. (E,F) Quantification
of the data presented in A-D showing increased
proportions of RGCs (E11.5) and BPs (E11.5 and
E12.5) undergoing mitosis. (G,H) BrdU/PCNA
immunohistochemistry on sections of E12.5 control
and Gli3cKO embryos that were treated with BrdU
24 h earlier. (I,J) BrdU immunofluorescence staining
on sections of E17.5 control (I) and Gli3cKO embryos
(J) to reveal neurons born at E12.5. Only the
cortical plate (CP) is shown. (K) Quantification of
the data presented in G-J showing decreased cell
cycle exit and neuron formation in Gli3cKO embryos.
All statistical data are presented as mean±95% CI;
n=6 (A,B) and n=4 (C,D,G-J); *P<0.05; Mann–
Whitney test. Scale bar: in A, 25 µm for A-D,G-J.
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tested whether these sites can specifically bind a GST-Gli3 protein
containing the Gli3 DNA-binding domain. Incubation of GST-Gli3
with oligonucleotides containing the Gli-binding motif from the
Cdk6 promoter resulted in the formation of a slower migrating
complex (Fig. 5D,E). Competition assays in the presence of various
amounts of surplus unlabelledwild-type oligonucleotide (competitor)
Fig. 3. See next page for legend.
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resulted in progressively diminished binding of GST-Gli3 fusion
protein with increasing amounts of competitor (Fig. 5D,E). However,
complex formation was not competed by unlabelledCdk6 competitor
oligonucleotide containing a GG to AT exchange (Fig. 5D,E), which
abolishes Gli binding (Hepker et al., 1999), suggesting that Gli3 can
specifically bind to sequences within the Cdk6 promoter.
We further explored the functionality of the Gli3-binding sites
using luciferase reporter assays in HEK293 cells. We cloned a
3.35 kb fragment immediately upstream of the Cdk6 transcriptional
start site into the promoterless luciferase reporter plasmid pGL4.10.
Transfecting this construct into HEK293 cells resulted in robust
induction of luciferase activity (Fig. 5F). However, co-transfection of
the Cdk6 promoter/luciferase reporter construct with a Gli3 repressor
expression plasmid (Persson et al., 2002) strongly reduced reporter gene
expression. In contrast, mutations in the Gli3-binding sites led to strong
promoter activity (Fig. 5F) but levels were lower than for the wild-type
construct and the promoter could still be repressed by co-transfection
of a Gli3 repressor construct, potentially due to non-consensus
Gli-binding sites (Vokes et al., 2008). Taken together, these
analyses demonstrate that Gli3 can specifically bind to sequences
in the Cdk6 promoter region and repress Cdk6 promoter activity.
Interfering with Cdk6 function restores the onset of
neurogenesis in Gli3cKO mutants
Next, we investigated a potential role of Cdk6 as a Gli3 downstream
target to control the timing of cortical neurogenesis. Activated Cdk6
phosphorylates a number of proteins, including the retinoblastoma
(Rb) proteins, which upon their hyperphosphorylation release
the E2F transcription factors from inactive Rb/E2F complexes.
E2F factors activate the G1-S transcriptional programme necessary
for progression into S phase (Choi and Anders, 2014). Many of the
genes characteristic of this programme, including Cdc6, Mcm2-7,
Cdt1, the E2Fs E2f1 and E2f2 and cyclin E1 and cyclin E2 are
upregulated in E11.5 Gli3cKO embryos. We also examined the
phosphorylation status and the distribution of the Rb protein in
Gli3 mutant cortical progenitor cells. Cyclin/Cdk complexes are
known to phosphorylate Rb at specific residues including Ser-780
(Ely et al., 2005; Kitagawa et al., 1996; Zarkowska and Mittnacht,
1997). In the rostromedial telencephalon of E11.5 and E12.5
embryos, most pRb-S780-positive cells were located at the
ventricular surface where RGCs undergo mitosis before they enter
G1 phase. In E11.5 Gli3cKO embryos, the proportion of pRb-S780-
positive cells with respect to the total number of proliferative cells was
increased but there was no significant change at E12.5, which is
consistent with the shortening and elongation of the cell cycle at
E11.5 and E12.5, respectively (Fig. 6A-E). Overall, these data
indicate that the upregulation of Cdk6 in Gli3 conditional mutants
coincides with an increased phosphorylation of Rb at Ser780 in
cortical progenitor cells and with an upregulation of the G1-S
transcriptional programme, suggesting that increased levels of Cdk6
transcription prematurely drive progenitor cells into proliferation.
Finally, we directly tested whether the upregulation of Cdk6
underlies the delayed cortical neurogenesis in Gli3cKO embryos.
To this end, we made use of palbociclib, which selectively inhibits
Cdk4/6 with high specificity (Fry et al., 2004) and treated E10.5
pregnant mice either with lactate buffer as vehicle or with a single
dose of 75 mg palbociclib/kg body weight before analysing embryos
24 h later. This dose has previously been shown to reduce Cdk4/6
activity in embryos but not to completely block Cdk4/6 function
(Fry et al., 2004). In control experiments, we first determined the
effects of these treatments on the phosphorylation of Rb as a direct
target of the Cdk4/6 kinases. Immunohistochemistry confirmed
that the proportion of pRb-S780-positive cells relative to the total
number of PCNA+ proliferative cells was increased in Gli3cKO
embryos treated with vehicle but did not differ between control and
Gli3cKO embryos after palbociclib treatment (Fig. 6F-J), indicating
that this regimen resulted in the reduction of Cdk4/6 activity to
control levels. Next, we analysed the formation of cortical neurons.
Under control conditions, the proportion of neurons was reduced
in Gli3cKO embryos, consistent with our previous findings
(Fig. 6K,L,O). In contrast, treating with palbociclib restored the
proportion of cortical neurons (Fig. 6M-O). We also tested whether
Cdk6 inhibition at a later stage could also affect cortical neurogenesis
in Gli3cKO embryos. To this end, we repeated the palbociclib
regimen with E11.5 pregnant mice, which were also injected with
a single dose of BrdU, and determined the proportion of newly
born Tbr1+BrdU+ neurons 24 h later. This analysis revealed a
slight increase in the proportion of newly formed neurons in
Gli3cKO embryos under control conditions; however, this was not
further increased after palbociclib treatment (Fig. S8). Taken
together, these findings strongly support the hypothesis that Cdk6
acts as a downstream target of Gli3 to control the onset of neuron
formation in the cortex.
DISCUSSION
Patterning and growth of the developing cerebral cortex have to
be tightly coordinated to allow for the formation of appropriate
types and numbers of neurons in time and space. Here, we show that
the transcription factor Gli3, which has previously been implicated
as a key regulator of cortical patterning, has an additional role
in controlling the onset of cortical neurogenesis. Cortex-specific
inactivation of Gli3 resulted in the delayed formation of neurons.
This defect is caused by a shortening of the cell cycle and in
particular the lengths of G1 and S phases. Moreover, Gli3 negatively
regulates Cdk6 expression levels and pharmacological interference
with Cdk6 function rescues the early delay in neurogenesis caused by
cortical Gli3 inactivation, indicating that Gli3 controls early cortical
neurogenesis by regulating Cdk6 expression levels.
Controlling the onset of neurogenesis represents a key
requirement for forming a cortex of the appropriate size, but how
this control is achieved remains largely unknown. Here, we show
that Gli3 inactivation in cortical progenitors led to a delay in the
formation of the earliest cortical neurons, indicating a novel role
Fig. 3. Gli3 conditional inactivation affects cortical size and architecture.
(A,B) Dorsal views of E18.5 control (A) and Gli3cKO (B) brains. Gli3cKO embryos
only form a small olfactory bulb-like structure in the rostral telencephalon,
which is not visible in this dorsal view (Amaniti et al., 2015). (C) Graph
comparing the surface area of control and Gli3cKO cerebral cortices.
(D-L) Immunohistochemistry on E17.5 control and Gli3cKO brains using the
indicated antibodies. (D-F) Tbr1+ neurons occupy a reduced area in the deep
cortical plate of theGli3cKO cortex. (G-I) Ctip2+ neurons occupy deeper positions
in the cortical plate of Gli3cKO embryos. (J-L) Distribution of Satb2+ upper layer
neurons, which have not completed their migration at this stage. (M-O) Tbr1 and
Ctip2 double immunofluorescence on coronal sections of E17.5 brains showed
that the relative position of Tbr1+ layerVI andCtip2+ layerV neurons ismaintained
inGli3cKO embryos. Moreover, the proportion of Tbr1+Ctip2+ double positive
neurons (arrowheads) is reduced in themutant (O). (P-U) The formation of Tbr1+
neurons is delayed in Gli3cKO embryos. (P-R) The proportion of Tbr1+ neurons
bornat E12.5 (arrowheads) is reduced inGli3cKOembryos. (S-U)BrdUbirthdating
at E13.5 showed an increase in BrdU+Tbr1+ neurons (arrowheads) in Gli3cKO
embryos. Note the large number of BrdU+Tbr1− neurons (arrows) superficial to
the Tbr1 domain in control embryos. All statistical data are presented as mean
±95% CI; n=6 (A-C) and n=4 (D-U); *P<0.05; **P<0.01; ***P<0.005; Mann–
Whitney test (C,O,R,U) and two-way ANOVA followed by Sidak’s multiple
comparisons test (F,I,L). MZ, marginal zone; VZ, ventricular zone. Scale bars:
in A, 2 mm for A,B; in D,M, 50 µm for D,E,G,H,J,K,M,N,P,Q,S,T.
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for Gli3 in controlling the onset of neurogenesis. Interestingly, a
previous study using NestinCre;Gli3 conditional mutants identified a
bias towards the formation of deep layer neurons at the expense of
upper layer neurons (Wang et al., 2011). These different findings
might be explained by differences in the timing of Gli3 inactivation,
indicating temporal-specific roles ofGli3 at the onset of neurogenesis
and at later neurogenic stages. A time-dependent function in cortical
neuron formation is also supported by our palbociclib experiments.
Gene expression profiling led us to hypothesize that changes in
cell cycle regulation underlie the delayed neurogenesis in the Gli3
mutants. This idea is consistent with previous findings implicating
the cell cycle as a pivotal regulator of cortical neurogenesis.
In particular, the length of the G1 phase plays a major role.
It increases during neurogenesis and artificial lengthening of G1
leads to premature neurogenesis (Calegari and Huttner, 2003;
Lange et al., 2009; Pilaz et al., 2009). G1 length is mainly regulated
by Cdk4/6/cyclin D complexes, which form a central node in a
complex signalling network that promotes the G1-S transition
(Choi and Anders, 2014). Activation of the Cdk4/6 kinase, which is
Fig. 4. Cell cycle length of cortical progenitors is affected inGli3cKO embryos. (A) BrdU/IdU double labelling experiments to determine total cell cycle length (TC)
and S-phase duration (TS), which were calculated from counts of IdU+BrdU− and IdU+BrdU+ cells as described (Martynoga et al., 2005). E11.5 Gli3cKO embryos
show a shortening of TC and TS. The schematic illustrates the timing of IdU and BrdU injections and the progression of labelled cells in the cell cycle. (B) BrdU labelling
experiments to investigate the duration of G2 (TG2). Double labelling for BrdU and pHH3 determined the proportion of BrdU+/pHH3+ cells (arrows). TG2 corresponds to
the timewhen 50%of pHH3+ cells are BrdU+ (indicated by the dotted lines) and is not significantly altered between E11.5 control andGli3cKO embryos. (C) Determining
M-phase length (TM) using immunostaining for pHH3 andPCNA,which labelmitotic and proliferating cells, respectively. The fraction ofmitotic cellsmultiplied by total cell
cycle length provides TM duration, which is not significantly altered in E11.5 Gli3cKO embryos. (D) Pie charts summarizing the length of total and individual cell cycle
phases inE11.5 andE12.5 control andGli3cKO embryos. ShorterG1 andSphases contribute to a shortening of the overall cell cycle at E11.5whereasTC is increased at
E12.5 due to longer S and M phases. All statistical data are presented as mean±95% CI; n=4; *P<0.05; Mann–Whitney test. ns, not significant. Scale bars: 50 µm.
Table 1. Summary of cell cycle times in Gli3 mutant cortex
TC (h) TS (h) TG2 (h) TM (h) TG1 (h)
E11.5
Control 12.5 7.7 1.5 0.8 2.5
Gli3cKO 10.0 6.8 1.5 0.8 0.9
E12.5
Control 11.8 7.5 1.5 1.1 1.7
Gli3cKO 13.5 9.4 1.5 1.2 1.4
Statistically significant changes in cell cycle times are indicated in bold; red
represents a downregulation, green an upregulation.
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controlled by a multitude of signalling cues converging on the
Cdk4/6 node, leads to Rb hyperphosphorylation and subsequent
release of the E2F transcription factors. These factors in turn activate
the G1/S transcriptional programme, which includes the expression
of genes encoding proteins that are involved in the formation of
the pre-recombination complex, DNA synthesis and DNA repair
(Choi and Anders, 2014).
We present multiple lines of evidence that Gli3 controls the
G1 length at the onset of neurogenesis by directly regulating Cdk6
expression levels. Cortex-specific inactivation of Gli3 led to a
shortening of G1 at the start of neurogenesis, to an upregulation
of Cdk6 and to a concomitant activation of genes of the G1/S
transcriptional programme. We also show that Gli3 binds to the
Cdk6 promoter in vitro and in vivo as in the developing limb
(Lopez-Rios et al., 2012; Vokes et al., 2008), and that its activity
is repressed by Gli3. Finally, pharmacological interference with
Cdk6 kinase activity using the highly specific inhibitor palbociclib
(Fry et al., 2004) specifically rescued the delayed start of
neurogenesis in Gli3cKO embryos but had no effect at a later
neurogenic stage. Taken together, these findings strongly implicate
Gli3 as a direct regulator of Cdk6 and hence G1 length in RGCs.
Interestingly, Pax6 also controls Cdk6 transcription (Mi et al., 2013)
and essential Pax6-binding sites are in close proximity to the
Gli3-binding sites (K.H.-T. and T.T., unpublished) raising the
possibility that both transcription factors might interact to control
Cdk6 expression levels in RGCs. Thus, in addition to post-
translational control of Cdk6 kinase activity, controlling Cdk6
mRNA levels constitutes an important regulatory mechanism to
fine-tune the balance between proliferation and differentiation in
cortical RGCs.
Though delayed, the switch from proliferative to neurogenic
divisions eventually occurs in Gli3 mutant RGCs. Despite Cdk6
still being upregulated in E12.5 Gli3cKO embryos, the cell cycle
is significantly longer with no change in G1 phase length compared
with control embryos. Also, Rb-S780 phosphorylation is no
longer increased. To promote G1 progression, Rb phosphorylation
Fig. 5. Gli3 represses Cdk6 expression. (A) Representative example of qRT-PCR analyses showing increased Gli3 mRNA expression in the rostromedial
telencephalon of E11.5 and E12.5 Gli3cKO embryos. (B) Western blot analysis showing upregulation of Cdk6 expression in the dorsal telencephalon of
E12.5 ofGli3cKO embryos. Data expressed as Cdk6 expression relative to GAPDH, which served as a loading control. A paired t-test was used to evaluate relative
Cdk6 expression levels in four control/Gli3cKO embryo pairs derived from four different litters. (C) Gli3 chromatin immunoprecipitation followed by sequencing
revealed several peaks that are associated with the Cdk6 promoter region. Gli3 ChIP-seq reads were normalized to input. (D,E) Electromobility shift assays
showing in vitro binding of recombinant Gli3 protein to binding sites 1 (D) and 2 (E) in the Cdk6 promoter (lane 2). Complex formation is competed by increasing
amounts of wild-type oligonucleotide (lanes 3 and 4) but not by oligonucleotides containing the indicated point mutations in the Gli3-binding sites (lanes 5 and 6).
(F) Gli3 represses Cdk6 promoter activity in luciferase assays. Firefly luciferase activity was measured relative to Renilla luciferase control in HEK293 cells
transfected with the indicated constructs. pGL4 is the promoterless vector used to make the Cdk6 promoter construct (Cdk6), which was either co-transfected
with a GFP expression vector (GFP) or with a Gli3 repressor (Gli3R) construct. Data are representative of one of three independent experiments each using
three technical replicates. All statistical data are presented as mean±95% CI; n=4 (A E11.5 embryos,B); n=3 (A E12.5 embryos,F); *P<0.05; **P<0.01;
***P<0.001; unpaired t-test (A); paired t-test (B); two-way ANOVA followed by Tukey multiple comparisons tests (F).
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must surpass a threshold (Blomen and Boonstra, 2007). This
phosphorylation, however, depends on the sequential activity of
Cdk4/6/cyclin D and Cdk2/cyclin E complexes, which are negatively
regulated by the Cdk inhibitors Cdkn1a, b and c (Lim and Kaldis,
2013). According to our gene expression profiling, these inhibitors
are only downregulated in E11.5 but not in E12.5 Gli3cKO embryos.
Therefore, the activity levels of the Cdk complexes might not be
sufficient to surpass the Rb phosphorylation threshold at E12.5,
which might also explain the time-limited effect of the palbociclib
treatment. The resulting prolonged cell cycle, a characteristic feature
of differentiative divisions (Calegari et al., 2005; Caviness et al.,
1995; Takahashi et al., 1995), could indicate a compensatory switch
from self-renewing to neurogenic divisions corresponding with the
increased neuron formation in the Gli3 mutants at the later stage.
Although evaluating the role of the G1 phase has gained much
attention, recent work suggested the importance of S phase in cortical
development. Cortical stem and progenitor cells shorten S phase on
commitment to neuron production with the length of other cell cycle
phases remaining unaltered (Arai et al., 2011). S-phase length is also
themost distinguishing feature between progenitor cell populations in
ferret cortex (Turrero García et al., 2016). A stronger requirement
for DNA repair and replication fidelity in proliferative versus
differentiating progenitors is thought to underlie a longer S phase,
suggesting that S phase is a key factor in maintaining the proliferative
capacity of neural progenitor cells (Arai et al., 2011; Soufi andDalton,
2016). Despite this pivotal role, it remains largely unknown whether
and how S-phase duration is controlled by cortical transcription
factors. Interestingly,Gli3 cortical inactivation led to a shorter S phase
in cortical progenitors. This change is not due to a shift in the
proportion from proliferating to differentiating progenitors, which
have a shorter S phase (Arai et al., 2011), or due to a change in the
proportions of apical progenitors andBPs.Rather, S-phase shortening
is likely to reflect an intrinsic change of Gli3 mutant RGCs as these
cells make up the vast majority of progenitors in the E11.5
rostromedial telencephalon. The consequences of this S-phase
shortening are currently unclear but, based on the above model, one
would predict an increase in neurogenesis, whichwe do observe 1 day
later. Thus, the shorter S phase might be an early indicator of a switch
towards asymmetric neurogenic divisions.
There are several mutually non-exclusive possibilities for how Gli3
could regulate S-phase duration. First, the upregulation of the G1/S
programmemay allow for faster progression through S phase. Second,
Gli3 might directly control the expression of genes determining
S-phase length. Indeed, an upregulation of cyclin A2, which regulates
S-phase progression (Yam et al., 2002), in combinationwith a reduced
expression of the cyclin inhibitors Cdkn1a, b and c could induce
RGCs to progress faster through S phase. Finally, S phase involves
the control of DNA quality and repair and a large number of DNA
repair genes are upregulated (differentially expressed) in E11.5
Gli3cKO mutants. Interestingly, there is a large overlap in this set of
Gli3-regulated genes with E2F target genes (Ren et al., 2002). As
E2F genes are upregulated in Gli3cKO embryos, this finding raises
the interesting possibility that Gli3 regulates S-phase length in RGCs
by controlling the expression levels of the E2F transcription
factors, which integrate cell cycle progression with DNA repair
and replication (Ren et al., 2002).
Fig. 6. Interfering with Cdk6 kinase activity rescues the early delay in neurogenesis in Gli3cKO embryos. (A-D) Immunohistochemistry showing
expression of pRb-S780 and PCNA in E11.5 (A,B) and E12.5 (C,D) control and Gli3cKO embryos. (E) Quantification of the proportion of pRb-S780+/PCNA+
cells, which is increased inGli3cKO embryos at E11.5. (F-I) Immunostaining for pRb-S780 and PCNA in E11.5 control andGli3cKO embryos 24 h after treatment
with lactate as vehicle or with theCdk6 inhibitor palbociclib. (J) Quantification of the pRb-S780+/PCNA+ cell proportion after treatment with lactate or palbociclib.
(K-N) Immunohistochemistry for Tbr1 revealing the proportions of neurons in E11.5 control and Gli3cKO embryos after lactate or palbociclib administration.
(O) Quantification of the immunostaining in K-N. All statistical data are presented as mean±95% CI; n=4 (B,D); n=6 (A,C); n=7 (F-I,K-N); *P<0.05*; **P<0.01;
***P<0.005; Mann–Whitney test (E); ANOVA with Tukey multiple comparisons test (J,O). bv, blood vessels. Scale bar: in A, 50 µm for A-D,F-I,K-N.
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Taken together, our findings reveal that Gli3 controls the onset
of cortical neurogenesis by regulating Cdk6 expression levels and
G1-phase length. Besides identifying Cdk6 as Gli3’s first target
gene during corticogenesis, our results have major implications
for cortical development in health as well as for human disease.
Formation of the cerebral cortex requires a tight balance between
proliferation and differentiation of RGCs to determine neuron
numbers and, eventually, cortical size. A delayed onset of neurogenic
divisions is predicted to lead to an increased number of radial units
and to an overproduction of later-born cortical neurons at the expense
of early-born neurons. These changes alter the size and laminar
composition of the cortex, as observed in Gli3cKO mutants, which is
likely to affect cortical cytoarchitecture and function. Moreover,
prolonged proliferation of cortical progenitor cells could not only
underlie the macrocephaly in acrocallosal syndrome patients who
carry mutations inGLI3, but also the agenesis of the corpus callosum
in these patients (Bonatz et al., 1997; Elson et al., 2002; Philip et al.,
1988; Schinzel, 1979). In Gli3cKO mutants, the rostral midline
becomes elongated and eventually starts to fold, with glial cells
specifically forming at these folds but not in the rest of the cortex.
The resulting ectopic glial fibres later interfere with midline crossing
of callosal axons (Amaniti et al., 2013). Interestingly, such folds are
still present in the cingulate cortex of Gli3cKO postnatal animals
(Amaniti et al., 2013). Similar glial abnormalities have also been
observed in ciliary mouse mutants with callosal malformation
(Benadiba et al., 2012; Laclef et al., 2015), suggesting that
proliferation defects might also contribute to the malformation of
the corpus callosum in thewider group of ciliopathies. Taken together,
these wider considerations emphasize the importance of Gli3 in




All experimental work was carried out in accordance with the UK Animals
(Scientific Procedures) Act 1986 and UK Home Office guidelines.
All protocols were reviewed and approved by the named veterinary
surgeons of the College of Medicine and Veterinary Medicine, the
University of Edinburgh, prior to the commencement of experimental work.
Flag-Gli3, Emx1Cre and Gli3flox/flox mouse lines have been described
previously (Blaess et al., 2008; Gorski et al., 2002; Nishi et al., 2015).
Emx1Cre;Gli3flox/+ and Gli3flox/flox mice were interbred to generate Gli3cKO
mutants. E0.5 was assumed to start at midday of the day of vaginal plug
discovery and Gli3flox/flox, Gli3flox/+;Emx1Cre and Gli3flox/+ embryos were
used as controls.Gli3flox/flox animals were interbred with Tis21-GFP animals
to generate Gli3flox/flox;Tis21GFP/GFP mice. Double transgenic females were
crossed with Emx1Cre;Gli3flox/+ males to obtain Emx1Cre;Gli3flox/flox;
Tis21GFP/+ conditional embryos. Transgenic animals and embryos were
genotyped as described (Blaess et al., 2008; Gorski et al., 2002; Haubensak
et al., 2004; Maynard et al., 2002; Ueta et al., 2002). For each marker and
each stage, four to seven embryos were analysed.
For BrdU and IdU incorporation experiments, pregnant females were
injected intraperitoneally with 100 mg of BrdU per gram body weight.
Palbociclib was administered by oral gavage at 75 mg/kg body weight in
lactate buffer (50 mM, pH 4.0) and animals were killed 24 h later.
Immunohistochemistry and histology
Immunohistochemical analysis on 12 µm cryosections was performed as
described previously (Theil, 2005) using antibodies against the following
antigens (Table S2): rabbit anti-BrdU (1:50, Abcam, ab6326), mouse anti-
BrdU (1:50, Becton Dickinson, 347580), rat anti-Ctip2 (1:1000, Abcam,
18465), chick anti-GFP (1:1000, Abcam, 13970), goat anti-Gli3 (1:200,
R&D Systems, AF3690), rabbit anti-Pax6 (1:400, BioLegend, 901301),
mouse anti-PCNA (1:500, Abcam, 29), rabbit anti-pHH3 (1:100,
Millipore, 06-570), rabbit anti-phospho-Rb-S780 (1:200, Cell Signaling,
9307), mouse anti-Satb2 (1:200, Abcam, 51502), rabbit anti-Tbr1 (1:400,
Abcam, 31940), rabbit anti-Tbr2 (1:1000, Abcam, 23345). Primary
antibodies for immunohistochemistry were detected with Alexa-conjugated
(1:200, Invitrogen) or Cy2/3-conjugated (1:100, Jackson ImmunoResearch)
fluorescent secondary antibodies. The Gli3 and Tbr1 signals were amplified
using biotinylated secondary IgG antibodies (Gli3: rabbit anti-goat IgG;
Tbr1: swine anti-rabbit IgG) (1:400, Becton Dickinson) followed by Alexa
Fluor 488 or 568 Streptavidin (1:200, Invitrogen). For counterstaining, TO-
PRO-3 (1:2000, Invitrogen) or DAPI (1:2000, Life Technologies) were used.
For measuring S-phase lengths and total cell cycle lengths, pregnant
females received a single, intraperitoneal injection of IdU, followed by an
injection of BrdU 90 min later. Embryos were collected 2 h after the initial
injection. To determine G2 length, pregnant females were treated with a
single dose of BrdU, embryos were harvested 60, 90 or 120 min after BrdU
administration and the proportion of BrdU+/pHH3+ cells was determined
for each time point. Measurements of M-phase length involved determining
the proportion of pHH3+/PCNA+ cells compared with the total number of
PCNA+ cells. To determine the generation of neurons by pulse-chase
experiments, pregnant females were intraperitoneally injected with BrdU.
Embryos were harvested 24 h later and stained for BrdU and PCNA. The
fraction of cells that had left the cell cycle and differentiated into neurons
was calculated by dividing the number of BrdU+ PCNA− cells by the total
number of BrdU+ cells.
Quantifications of the dorsal surface area of the cortical hemispheres was
obtained by outlining the cortex on images of whole brains. To calculate the
length of the ventricular surface and cortical thickness lines were drawn on
images of DAPI-stained coronal sections. Area and length measurements
were performed using Fiji software.
Western blot
Protein was extracted from the rostromedial telencephalon of E12.5
wild-type and Gli3cKO embryos as described previously (Magnani et al.,
2010). Protein lysates (30 μg) were subjected to gel electrophoresis on a
4-12% gradient NuPAGE Bis-Tris gel (Life Technologies), and protein
was transferred to a PVDF membrane, which was incubated with rabbit
polyclonal anti-Cdk6 antibody (1:300; Santa Cruz Biotechnology, sc-177)
and mouse anti-GAPDH antibody (1:5000, Applied Biosystems, AM4300).
After incubating with anti-rabbit IgG IRDye800CW (1:15,000, LI-COR
Biosciences) and anti-mouse IgG Alexa Fluor 680 secondary antibodies
(1:5000, Life Technologies), signal was detected using Odyssey Infrared
Imaging System with Odyssey Software (LI-COR Biosciences). Values for
protein signal intensity were obtained using Image Studio Lite Version3.1.
Cdk6 protein levels were compared between wild-type and mutant tissue
using a paired t-test.
Electrophoretic mobility shift assays
For the GST-Gli3Zf construct, the cDNA encoding the Gli3 DNA-binding
domain was PCR amplified and subcloned into the pGEX4-T3 vector using
the SalI andNotI restriction enzyme sites. Oligonucleotides used for cloning
are summarized in Table S1. Electrophoretic mobility assays were performed
with biotin-labelled oligonucleotides from the Cdk6 promoter and purified
GST and GST-Gli3-Zf proteins as described previously (Hasenpusch-Theil
et al., 2017). The binding reactions were separated on native 5% acrylamide
gels and transferred onto positively charged nylon membranes (Roche) with a
Perfect Blue Semi-dry electro blotter (60 min at 120 V, 5 mA). After UV
crosslinking, biotin-labelled probes were detected using a Chemiluminescent
Nucleic Acid Detection Module (Thermo Fisher Scientific) according to
manufacturer’s instructions and imaged using a Kodak BioMaxXAR film.
For oligonucleotide sequences covering the wild-type or mutated
Gli3-binding sites, see Table S1. The exchanged nucleotides in the
mutated forms are underlined. Wild-type and Gli3-binding site mutant
oligonucleotides were used as specific and non-specific competitors,
respectively, in a 10- to 100-fold molar excess.
Luciferase assay
Genomic DNA fragments from the Cdk6 promoter were generated via PCR
with the oligonucleotides listed in Table S1 from BAC clone RP23-53P17,
subcloned using pCR-Blunt II-TOPO cloning kit (Invitrogen) and verified
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by sequencing. A 3.35 kb Cdk6 promoter fragment was subcloned into
the pGL4.10 promoterless firefly luciferase reporter vector (Promega) after
Asp718 and XhoI restriction digests. HEK293 cells were transfected using
Lipofectamine 2000 (Invitrogen). Gli3 repressor and GFP were expressed
from previously described pCAGGS expression vectors (Persson et al.,
2002). The Renilla luciferase vector was pRLSV40 (Promega). HEK293
cells were harvested 48 h after transfections and analysed with the Dual
Luciferase Reporter Assay System (Promega).
RNAseq, qRT-PCR, ChIPseq and bioinformatic analyses
For RNAseq experiments, rostromedial dorsal telencephalic tissue was
dissected from E11.5 and E12.5 embryos and pooled (E11.5: six tissues;
E12.5: three tissues) to generate four different replicates per genotype (control:
Emx1Cre;Gli3flox/+; mutant:Emx1Cre;Gli3flox/flox). Total RNAwas extracted
using RNeasy Plus Mini Kit (Qiagen). After assessing the integrity of the
RNA samples with an Agilent 2100 Bioanalyzer, (RIN>8), all RNAs were
further processed for RNA library preparation and sequenced (paired-end,
50 bp/100 bp reads) on an Illumina SOLEXA GAII platform at Edinburgh
Genomics (University of Edinburgh). Sequence reads were aligned with
NCBI build 38 for Mus musculus and analysed using Genomatix Software
Suite (Genomatix, Munich) based on the ElDorado 12-2013 database and
Genomatix GenomeAnalyzer (GGA). The number of differentially expressed
genes was determined using Ensemble as the source of transcripts and DeSeq
1.10.1 as the differential expression method with a threshold P-value ≤0.05.
Differentially expressed genes were analysed for gene ontology using
Genomatix Pathway Systems (GePS) and GeneRanker (Berriz et al., 2003).
GePS allows networks to be created based on literature, and GeneRanker
includes more in-depth filtering with Gene Ontology or Genomatix
proprietary annotation. To identify putative Gli3-binding sites in the
3.35 kb upstream promoter region of Cdk6, the sequence was run through
MatInspector of the Genomatix Software using the Gli3 weight matrices V
$GLI3.01 AND V$GLI3.02. Identified binding sites were ranked by
matrix similarity scores and the highest ranked sequences were chosen for
further analysis. To validate differential expression of Cdk6, total RNA
was isolated from the rostromedial telencephalon of E11.5 and E12.5
control and Gli3cKO embryos using an RNeasy Plus Micro Kit (Qiagen)
and reverse transcribed using ImProm-II Reverse Transcriptase (Promega).
Quantitative reverse transcription PCR (qRT-PCR) was performed using
QuantiTect SYBRGreen (Qiagen) and aDNAEngine Opticon System (GRI);
the oligonucleotides used are summarized in Table S1. For each sample,
Ct values were extrapolated using the Opticon software and ratios of relative
gene expression levels of β-actin (reference gene) and Cdk6 were calculated
based on a modified ΔΔCt method taking into account different PCR kinetics
(Pfaffl, 2001); PCR efficiencies are summarized in Table S3.
Chromatin immunoprecipitation followed by sequencing (ChIP-seq)
was performed on E12.5 cerebral cortices derived from Flag-Gli3 mice
(Nishi et al., 2015) using a Millipore Magna ChIP A/G kit and anti-Flag M2
antibody (Sigma) on 1×106 cells. Two independent ChIP experiments
were sequenced on an Illumina Hiseq 2000 platform. Illumina sequencing
adapters were trimmed off with Trimmomatic v0.36 software and ChIP-seq
reads were aligned to the genome using Bowtie2. The MACS2 (model-based
analysis of ChIP-seq) programmewas used for peak calling withmfold values
150-200 and q-value cutoff at 0.001. For graphical illustration, Gli3 ChIP
samples were normalized to input samples using bamCompare.
Statistical analyses
Data were analysed using GraphPadPrism 6 software with n=3-7 embryos
for all analyses. Power analysis of pilot experiments informed minimum
samples size. Mann–Whitney tests were in general performed for
immunohistochemical analyses and for measurements of cortical surface
area. The distribution of Tbr1+, Ctip2+ and Satb2+ neurons was analysed
using a two-way ANOVA followed by Sidak’s multiple comparisons test.
For the palbociclib rescue experiment, ANOVA with Tukey’s multiple
comparisons test was performed (*P<0.05, **P<0.01,***P<0.001). For
quantifications of the palbociclib rescue experiment, the observer was blinded
to the experimental treatments. Owing to morphological changes, blinding
was not possible for experiments involvingGli3cKO embryos older than E11.5.
In these cases, scores were validated by a second independent observer.
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